We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





BioPerfectus Presents Total PCR Solution at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023

Jiangsu Bioperfectus Technologies Co. More...

, Ltd. (Shanghai, China) is presenting its Total PCR Solution at Medlab Middle East 2023 that can improve operational and cost efficiency, optimize workflow, and increase performance at every opportunity.

Bioperfectus Total PCR Solution offers holistic products of extraction systems, extraction reagents, real-time PCR systems, and RT-PCR reagents. These products could cover PCR detection workflow and assure the users with reassuring results by validated performance. At Medlab Middle East 2023, Bioperfectus is highlighting the STC-96A Plus Real-Time PCR system that is a more-than-ever flexible, efficient and reliable breakthrough in the real-time PCR analysis of gene expression and genetic variation. Bioperfectus is also highlighting the SAW-96 automated nucleic acid extraction workstation, an in-vitro diagnostic medical device that integrates cutting-edge mechanical, electronic, and software technologies. In addition, Bioperfectus is showcasing the SSNP-2000B nucleic acid extraction system, which integrates new technologies such as machine, electricity and computer software to enable automatic nucleic acid extraction of 32 samples maximum in one time.

Among its other nucleic acid extraction solutions, Bioperfectus is highlighting the SMPE-960 nucleic acid extraction system which integrates cutting-edge mechanical, electronic and software technologies to enable automated extraction of nucleic acids from samples. Featuring a modular structure, the SMPE-960 can extract nucleic acids from 1-96 samples in three independently operating modules at the same time. Bioperfectus is also providing a glimpse of its new products to be launched soon, including the SSNP-A6 nucleic acid extraction system that can extract nucleic acids from 96 samples simultaneously to meet the requirement for high throughput laboratories, alongside the SSP-1196 automatic sample preparing system that enables automated capping, scanning of barcode, transfer of sample liquid to the extraction plate, decapping and ready to extraction.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Whole Blood Control
Lyphochek Whole Blood Control
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.